The findings, published June 22 in JAMA Neurology, should help identify people at the greatest risk of developing the disease.

Using the "sonodynamic" technique, UVA Medicine researchers reduced the total number of living cancer cells by nearly 50%.

High-contact athletes were three times more likely to have a blood brain barrier leak, with some who did not complain of severe symptoms also showing brain abnormalities on imaging.

They did find that patients with prior neurological conditions and those over age 60 were at an increased risk for developing new onset complications—including central nervous system infection, seizures and consciousness disorders.

Radiologists often mistake these bony lesions near the knee as more serious conditions, such as cancer, but researchers say such irregularities are typically benign.

Bracco subsidiary Blue Earth Diagnostics and PETNET Solutions, part of Siemens Healthineers, announced the multi-year agreement last week.

The Beloit, Wisconsin-based firm, known for producing molybdenum-99, is working with Chicago's Monopar Therapeutics on the treatment to battle severe cases of the disease.

“Black lives matter. The need to speak out against racism, racial injustice and inherent bias compels each of us as leaders in our community to act,” Founder and CEO Greg Piefer said in a recent message to employees.